101 – 110 of 116
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2004
 - 
                        Mark
        Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
    
    
- Contribution to journal › Article
 
 - 2003
 - 
                        Mark
        First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        More efficient mobilisation of peripheral blood stem cells with HiDAC plus AMSA plus G-CSF than with mini-ICE plus G-CSF in patients with AML
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        A Study of Renal Function in Children with Cancer
    (2003)
- Thesis › Doctoral thesis (compilation)
 
 - 2002
 - 
                        Mark
        C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Riktlinjer för handläggning av patienter med pankreascancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Chemoradiotherapy of esophageal cancer.
    
    
- Contribution to journal › Scientific review
 
 - 2001
 - 
                        Mark
        Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP
    
    
- Contribution to journal › Article